Log In
Print
BCIQ
Print
Print this Print this
 

Strattera, atomoxetine (formerly Tomoxetine)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSelective norepinephrine reuptake inhibitor (SNRI)
Molecular Target Norepinephrine transporter
Mechanism of ActionNorepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsMaintenance treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents; Treat attention deficit hyperactivity disorder (ADHD); Treat attention deficit hyperactivity disorder (ADHD) in children
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today